Earnings Play ---> SRDX sports a p/e of over 130, Growth expections are excellent at 48% growth for the next five years. But the caveat here is that technically the stock appears overbought and fundamentally has the market currently has priced in expectations higher than either of your projections? Can this stock keep moving up even with formidable insider selling in February. They are indeed cash heavy but it should be interesting to see if these valuation can be sustained, money flow and all. We can get a hint of what to expect in other companies with this report.
SurModics, Inc. to Webcast Second-Quarter Conference Call April 17
Webcast is Live at 4 p.m. (CDT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--April 12, 2001-- SurModics, Inc. (Nasdaq:SRDX - news), a leading provider of surface modification coatings for medical devices, today announced that it will host a live Webcast of its second-quarter conference call Tuesday, April 17, at 4 p.m. CDT.